2030年までの北米マイクロバイオーム治療薬市場予測 - 地域分析 - タイプ別（治療薬および処置）、アプリケーション別（代謝性障害および肥満、C.ディフィシル感染症、炎症性腸疾患など）、エンドユーザー別（病院および診療所、外来外科）センター、在宅ケア、その他）

北米のマイクロバイオーム治療薬市場は、2022年に1億6,164万米ドルと評価され、2030年までに3億4,299万米ドルに達すると予想されています。 2022 年から 2030 年にかけて 9.9% の CAGR を記録すると推定されています。マイクロバイオーム発見パイプラインを改善するための資金流入が北米のマイクロバイオーム治療薬市場を推進研究によると、マイクロバイオームの不均衡や混乱が、炎症性腸疾患などのさまざまな状態に寄与する可能性があることが示されています。肥満、精神的健康障害なども含まれます。健康全般におけるマイクロバイオームの役割が認識されることにより、マイクロバイオームを標的にして調節する治療法の開発に大きな関心が集まっています。さらに、技術と研究ツールの進歩により、マイクロバイオームの研究と操作が容易になりました。次世代シークエンシングとメタゲノム解析により、微生物群集とその機能をより深く理解できるようになりました。知識の増加により、標的療法の開発に新たな可能性が開かれました。米国食品医薬品局（FDA）などの規制当局も、マイクロバイオーム治療薬の開発を支援する意欲を示している。 FDA は FMT のガイドラインを確立し、安全性と有効性を確保する規制経路を通じてこの分野を前進させることに関心を表明しています。これらすべての要因が組み合わさって、マイクロバイオーム治療の分野に取り組む企業にとって有利な投資環境を生み出しました。強力な臨床証拠が利用可能になるにつれ、投資家はマイクロバイオーム調整企業に注目し始めています。資金調達の強化により、開発と生産の高コストに伴う課題を克服するために必要なリソースが企業に提供され、最終的にこの分野を前進させることができます。北米のマイクロバイオーム治療薬市場の概要健康の維持と病気の予防におけるヒトのマイクロバイオームの重要性に対する理解が進むにつれ、米国の研究者は、さまざまな症状を治療するための有望なアプローチとしてマイクロバイオームに基づく介入を探索するようになりました。さらに、北米のマイクロバイオーム治療薬市場におけるこの国の優位性は、主に革新的な治療法の開発に有利なよく発達した研究インフラに起因しています。さらに、肥満や炎症性腸疾患などの慢性疾患の有病率の上昇により、需要が生み出されています。革新的な治療法を目指し、マイクロバイオーム治療法の開発を促進します。遺伝子配列決定とバイオインフォマティクスにおける技術の進歩により、マイクロバイオームの研究と変更が可能になり、個別化されたマイクロバイオームに基づく介入の開発が促進されます。個別化医療への傾向は、オーダーメイドのマイクロバイオーム治療法とよく一致しています。学界、産業界、政府機関間の連携も研究開発の取り組みを促進し、科学的発見の商品化を加速させています。規制当局がマイクロバイオーム治療薬の可能性を認識し、開発と承認のためのガイダンスを提供するため、この分野への規制支援と投資は市場の成長にさらに貢献します。北米マイクロバイオーム治療薬市場の収益と2030年までの予測（百万米ドル）北米マイクロバイオーム治療薬市場のセグメンテーション北米のマイクロバイオーム治療薬市場は、種類、用途、エンドユーザー、および国に基づいて分割されています。種類に基づいて、北米のマイクロバイオーム治療薬市場は治療薬と処置に二分されます。 2022 年には処置部門がより大きなシェアを占めました。治療部門はさらに糞便微生物叢移植 (FMT)、プレバイオティクスおよびプロバイオティクスなどに細分化されています。北米のマイクロバイオーム治療薬市場は、用途別に、代謝障害と肥満、クロストリジウム・ディフィシル感染症、炎症性腸疾患などに分割されています。 2022年にはC.ディフィシル感染症セグメントが最大のシェアを占めた。エンドユーザー別では、北米のマイクロバイオーム治療市場は病院や診療所、外来手術センター、在宅医療などとなっている。 2022 年には病院および診療所セグメントが最大のシェアを占めました。北米のマイクロバイオーム治療薬市場は国ごとに米国、カナダ、メキシコに分割されています。 2022 年の北米マイクロバイオーム治療薬市場は米国が独占しました。AOBiome Therapeutics Inc、Ferring Holdings SA、Finch Therapeutics Group Inc、Pendulum Therapeutics Inc、Seres Therapeutics Inc は、北米のマイクロバイオーム治療薬市場で事業を展開する大手企業です。

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Microbiome Therapeutics Market Landscape

4.1 Overview

4.2 North America PEST Analysis

5. North America Microbiome Therapeutics Market - Key Industry Dynamics

5.1 North America Microbiome Therapeutics Market - Key Industry Dynamics

5.2 Key Market Drivers

5.2.1 Potential of Gut Microbiota in Maintaining Human Health

5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.3 Key Market Restraints

5.3.1 High Cost of Development and Production

5.4 Key Market Opportunities

5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.5 Key Future Trends

5.5.1 Technological Advancement in Human Microbiome Therapeutics

5.6 Impact of Drivers and Restraints:

6. Microbiome Therapeutics Market - North America Market Analysis

7. North America Microbiome Therapeutics Market Analysis - Type

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)

7.2 Procedure

7.2.1 Overview

7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)

8. North America Microbiome Therapeutics Market Analysis - Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview

8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)

8.2 C. Difficile Infection (CDI)

8.2.1 Overview

8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)

8.3 Inflammatory Bowel Disease

8.3.1 Overview

8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)

8.4 Others

8.4.1 Overview

8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

9. North America Microbiome Therapeutics Market Analysis - End User

9.1 Hospitals and Clinics

9.1.1 Overview

9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)

9.2 Ambulatory Surgical Centers

9.2.1 Overview

9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)

9.3 Homecare

9.3.1 Overview

9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)

9.4 Others

9.4.1 Overview

9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

10. North America Microbiome Therapeutics Market - Country Analysis

10.1 North America Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.1 North America Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.2 US

10.1.2.1 US: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.2.2 US: North America Microbiome Therapeutics Market Breakdown by Type

10.1.2.2.1 US North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.2.3 US: North America Microbiome Therapeutics Market Breakdown by Application

10.1.2.4 US: North America Microbiome Therapeutics Market Breakdown by End User

10.1.3 Canada

10.1.3.1 Canada: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.3.2 Canada: North America Microbiome Therapeutics Market Breakdown by Type

10.1.3.2.1 Canada North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.3.3 Canada: North America Microbiome Therapeutics Market Breakdown by Application

10.1.3.4 Canada: North America Microbiome Therapeutics Market Breakdown by End User

10.1.4 Mexico

10.1.4.1 Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.4.2 Mexico: North America Microbiome Therapeutics Market Breakdown by Type

10.1.4.2.1 Mexico: North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.4.3 Mexico: North America Microbiome Therapeutics Market Breakdown by Application

10.1.4.4 Mexico: North America Microbiome Therapeutics Market Breakdown by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in North America Microbiome Therapeutics Market

12. Company Profiles

12.1 Ferring Holdings SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Vedanta Biosciences Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Finch Therapeutics Group Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Pendulum Therapeutics Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Seres Therapeutics Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 AOBiome Therapeutics Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. North America Microbiome Therapeutics Market Segmentation

Table 2. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Type

Table 3. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Therapeutics

Table 4. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Application

Table 5. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - End User

Table 6. North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country

Table 7. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 8. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 9. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 10. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 11. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 12. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 13. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 14. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 15. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 16. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 17. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 18. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 19. Recent Growth Strategies in North America Microbiome Therapeutics Market

Table 20. Glossary of Terms, North America Microbiome Therapeutics Market

List of Figures

Figure 1. North America Microbiome Therapeutics Market Segmentation, By Country

Figure 2. North America PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030

Figure 5. North America Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030

Figure 6. Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 7. Procedure Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 8. North America Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030

Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 12. Others Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 13. North America Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030

Figure 14. Hospitals and Clinics Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 16. Homecare Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 17. Others Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 18. North America Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)

Figure 19. North America Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 20. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 21. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 22. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

1. AOBiome Therapeutics Inc

2. Ferring Holdings SA

3. Finch Therapeutics Group Inc

4. Pendulum Therapeutics Inc

5. Seres Therapeutics Inc

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America microbiome therapeutics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in North America microbiome therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth North America market trends and outlook coupled with the factors driving the microbiome therapeutics market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For North America Microbiome Therapeutics Market

WHAT'S INCLUDED IN FULL REPORT